Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Convertible Preferred Stock
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Notes Receivable
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Convertible Preferred Stock
Series E Preferred Stock
Common Stock
Series E Preferred Stock
Additional Paid-In Capital
Series E Preferred Stock
Series E1 Preferred Stock
Common Stock
Series E1 Preferred Stock
Additional Paid-In Capital
Series E1 Preferred Stock
Common Stock
Additional Paid-In Capital
Notes Receivable
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Total
BALANCE at Dec. 31, 2018 $ (276,889)                   $ 276,889                        
BALANCE (in shares) at Dec. 31, 2018 (84,092,669)                   84,092,669                        
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]                                              
Issuance of Preferred Stock                       $ 2 $ 134,665 $ 134,667   $ 24,977 $ 24,977            
Issuance of Preferred Stock (in shares)                       16,426,267     3,046,623                
BALANCE at Dec. 31, 2018   $ 11 $ 276,878 $ 276,889 $ 13 $ 283,318 $ (249) $ (190,666) $ (96) $ 92,320               $ 2 $ 6,440 $ (249) $ (190,666) $ (96) $ (184,569)
BALANCE (in shares) at Dec. 31, 2018   106,977,440     126,329,695                         19,352,255          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Exercise of Common Stock options                                     708       708
Exercise of Common Stock options (in shares)                                   1,217,255          
Vesting of restricted Common Stock                                   $ 1 7       8
Vesting of restricted Common Stock (in shares)                                   6,904,182          
Issuance of common stock for acquisitions                                     3,563       3,563
Issuance of common stock for acquisitions (in shares)                                   1,066,373          
Stock-based compensation expense                                     5,215       5,215
Common Stock warrants issued and exercised                                     1,038       1,038
Repayment of notes receivable                                     (249) $ 249      
Repayment of notes receivable (in shares)                                   (76,461)          
Net loss                                         (103,596)   (103,596)
Other comprehensive income                                           171 171
BALANCE at Dec. 31, 2019                                   $ 16 453,242   (294,262) 75 $ 159,071
BALANCE (in shares) at Dec. 31, 2019                                   154,913,934          
BALANCE (in shares) at Dec. 31, 2020                                             100,038,109
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Exercise of Common Stock options                                     325       $ 325
Exercise of Common Stock options (in shares)                                   521,925          
Vesting of restricted Common Stock                                   $ 1 6       7
Vesting of restricted Common Stock (in shares)                                   5,307,357          
Issuance of common stock for acquisitions                                     500       500
Issuance of common stock for acquisitions (in shares)                                   61,060          
Repurchase of shares for employee tax withholdings                                     (101)       (101)
Repurchase of shares for employee tax withholdings (in shares)                                   (9,308)          
Stock-based compensation expense                                     8,006       8,006
Common Stock warrants issued and exercised                                     1,915       1,915
Common Stock warrants issued and exercised (in shares)                                   692,366          
Reverse recapitalization, net of transaction costs                                   $ 6 530,040       530,046
Reverse recapitalization, net of transaction costs (in shares)                                   63,139,263          
Net loss                                         (90,432)   (90,432)
Other comprehensive income                                           (84) (84)
BALANCE at Dec. 31, 2020                                   $ 23 $ 993,933   $ (384,694) $ (9) $ 609,253
BALANCE (in shares) at Dec. 31, 2020                                   224,626,597